These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4698561)

  • 21. [Status of carbohydrate and lipid metabolism in children with kidney diseases].
    Enikeev RG
    Pediatriia; 1987; (6):106-7. PubMed ID: 3658588
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal prostaglandin E in renoparenchymal hypertension.
    Hsieh BS; Chen WY; Yen TS; Hsu HC
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):627-33. PubMed ID: 6389755
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of endothelin-1 and nitric oxide in the pathogenesis of hypertension in diabetic patients.
    Tomić M; Galesić K; Morović-Vergles J; Romić Z; Mikulić I
    Coll Antropol; 2008 Mar; 32(1):93-8. PubMed ID: 18496905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography of reserpine and rescinnamine using electrochemical detection.
    Wang J; Bonakdar M
    J Chromatogr; 1986 Oct; 382():343-8. PubMed ID: 2878006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical importance of the radioimmunologic determination of beta 2-microglobulin in patients with kidney pathology].
    Trusov VV; Filimonov MA; Kazakova IA; Marizin SA
    Ter Arkh; 1988; 60(11):117-20. PubMed ID: 2907187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of intrarenal hemodynamics in glomerulopathies].
    Kutyrina IM; Tareeva IE; Shestakova MV; Zverev KV
    Vestn Ross Akad Med Nauk; 1995; (5):47-52. PubMed ID: 7626986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma renin activity in patients with chronic nephritis.
    Kuska J; Kokot F
    Pol Med J; 1972; 11(5):1080-9. PubMed ID: 4648593
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbenicillin concentrations in normal and diseased kidneys. A therapeutic consideration.
    Whelton A; Carter GG; Bryant HH; Porteous LA; Walker WG
    Ann Intern Med; 1973 May; 78(5):659-62. PubMed ID: 4711770
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta 2-microglobulin: structure, function and clinical application (review of the literature)].
    Klimenko VS; Titov VN
    Lab Delo; 1984; (3):131-7. PubMed ID: 6200671
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W; Previato G; Bertoli M; Cancarini GC; Toigo G; Gasparotto ML; Romagnoli GF
    G Clin Med; 1975; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of desipramine-pretreatment to modify the initial concentration of reserpine in rat tissues.
    Manara L; Garattini S
    Eur J Pharmacol; 1967 Nov; 2(2):142-3. PubMed ID: 5583431
    [No Abstract]   [Full Text] [Related]  

  • 34. Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy.
    Tamura K; Yamauchi J; Tsurumi-Ikeya Y; Sakai M; Ozawa M; Shigenaga A; Azuma K; Okano Y; Ishigami T; Toya Y; Yabana M; Tokita Y; Ohnishi T; Umemura S
    Clin Exp Hypertens; 2008 Jan; 30(1):33-43. PubMed ID: 18214732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorimetric assay of reserpine in formulations and biological fluids.
    Karawya MS; Sharaf AA; Diab AM
    J Assoc Off Anal Chem; 1976 Jul; 59(4):795-8. PubMed ID: 939742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [KIDNEY DAMAGE IN DIABETES MELLITUS].
    TAKEUCHI J; SHINODA A
    Naika; 1964 Apr; 13():667-77. PubMed ID: 14151346
    [No Abstract]   [Full Text] [Related]  

  • 38. [INFORMATION DERIVED FROM THE KAPLAN ANGIOTENSIN TEST IN THE STUDY OF RENAL HYPERTENSION].
    DEROT M; GU'EDON J; TRAD J
    J Urol Nephrol (Paris); 1964; 70():723-30. PubMed ID: 14205992
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of felodipine in patients with impaired renal function.
    Edgar B; Regårdh CG; Attman PO; Aurell M; Herlitz H; Johnsson G
    Br J Clin Pharmacol; 1989 Jan; 27(1):67-74. PubMed ID: 2706189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.